share_log

Keros Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(4.2%),OrbiMed Capital GP VII LLC(3.7%), etc.

Keros Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-OrbiMed Advisors LLC(4.2%),OrbiMed Capital GP VII LLC(3.7%)等

美股sec公告 ·  2023/12/13 17:20
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息